Literature DB >> 20117027

Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes.

R Mariani1, S Pelucchi, C Arosio, S Coletti, M Pozzi, V Paolini, P Trombini, A Piperno.   

Abstract

Heterozygosity for p.Cys282YTyr is not ordinarily associated with a hemochromatosis phenotype, unless associated in the compound heterozygous state with other HFE mutations. The aims of the study were to identify factors responsible for iron overload in patients who were only heterozygous for p.Cys282Tyr at first genetic testing. Since 2001, twelve p.Cys282Tyr heterozygous patients with iron overload, defined by increased transferrin saturation, serum ferritin and hepatic iron stores, were identified. Four patients showed rare nonsense or missense HFE mutations in the compound heterozygous state with p.Cys282Tyr. One mutation (p.Gln233X) was never described before. The other 8 patients did not carry any other causal mutations in iron-related genes, but showed a very high prevalence of hepatic steatosis and steato-hepatitis, and metabolic alterations. Serum ferritin levels did not differ between the two groups, but transferrin saturation, hepatic iron amount and distribution significantly did. These last indices should be then strongly considered to decide for additional genetic characterization in p.Cys282Tyr heterozygotes. Our results also highlights the influence of metabolic alterations on serum iron indices and pattern of hepatic iron accumulation. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117027     DOI: 10.1016/j.bcmd.2010.01.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  4 in total

1.  CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.

Authors:  Sara Pelucchi; Raffaella Mariani; Stefano Calza; Anna Ludovica Fracanzani; Giulia Litta Modignani; Francesca Bertola; Fabiana Busti; Paola Trombini; Mirella Fraquelli; Gian Luca Forni; Domenico Girelli; Silvia Fargion; Claudia Specchia; Alberto Piperno
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.

Authors:  Patricia Aguilar-Martinez; Bernard Grandchamp; Séverine Cunat; Estelle Cadet; François Blanc; Marlène Nourrit; Kaiss Lassoued; Jean-François Schved; Jacques Rochette
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

3.  Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study.

Authors:  Philippe Saliou; Gérald Le Gac; Anne-Yvonne Mercier; Brigitte Chanu; Paul Guéguen; Marie-Christine Mérour; Isabelle Gourlaouen; Sandrine Autret; Cédric Le Maréchal; Karen Rouault; Jean-Baptiste Nousbaum; Claude Férec; Virginie Scotet
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

4.  Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia.

Authors:  Giulia Ravasi; Sara Pelucchi; Francesca Bertola; Martina Maria Capelletti; Raffaella Mariani; Alberto Piperno
Journal:  Genes (Basel)       Date:  2021-11-09       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.